Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Tumori
|
May 11, 2023
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report
Jacob Stein, Hannah E Kay, Jeremy Sites, et al.
Urology Case Reports
|
June 3, 2024
Inflammatory myofibroblastic tumor in a patient with X-Linked hypophosphatemia: A case of Occam's razor or Hickam's dictum?
Farhan Chowdry, Kelsey M Miller, Ersan Altun, et al.
Tumori
|
June 12, 2025
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement
Zachary S Feuer, Richard S Matulewicz, Ramsankar Basak, et al.
Urology
|
August 17, 2022
History of the Relationship Between Smoking and Bladder Cancer: A Public Health Perspective
Kristin G Weiss, Richard S Matulewicz, Elizabeth Moreton, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 27, 2022
Does histologic subtype impact overall survival in observed T1a kidney cancers compared with competing risks? Implications for biopsy as a risk stratification tool
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Investigational New Drugs
|
January 28, 2021
A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy
Toni K Choueiri, Michael B Atkins, Tracy L Rose, et al.
Clinical Genitourinary Cancer
|
February 14, 2021
Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Plos One
|
December 17, 2020
Development and validation of a NanoString BASE47 bladder cancer gene classifier
Jordan Kardos, Tracy L Rose, Ujjawal Manocha, et al.
Journal of the American College of Radiology : JACR
|
November 2, 2024
ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update
, Samantha J Barker, Esra Soylu, et al.
Current Problems in Cancer
|
April 21, 2023
Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot
Asia N Matthew-Onabanjo, Gabrielle Nortey, Richard S Matulewicz, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Tumori
|
May 11, 2023
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report
Jacob Stein, Hannah E Kay, Jeremy Sites, et al.
Urology Case Reports
|
June 3, 2024
Inflammatory myofibroblastic tumor in a patient with X-Linked hypophosphatemia: A case of Occam's razor or Hickam's dictum?
Farhan Chowdry, Kelsey M Miller, Ersan Altun, et al.
Tumori
|
June 12, 2025
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement
Zachary S Feuer, Richard S Matulewicz, Ramsankar Basak, et al.
Urology
|
August 17, 2022
History of the Relationship Between Smoking and Bladder Cancer: A Public Health Perspective
Kristin G Weiss, Richard S Matulewicz, Elizabeth Moreton, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 27, 2022
Does histologic subtype impact overall survival in observed T1a kidney cancers compared with competing risks? Implications for biopsy as a risk stratification tool
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Investigational New Drugs
|
January 28, 2021
A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy
Toni K Choueiri, Michael B Atkins, Tracy L Rose, et al.
Clinical Genitourinary Cancer
|
February 14, 2021
Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology
Jamie Michael, Nermarie Velazquez, Audrey Renson, et al.
Plos One
|
December 17, 2020
Development and validation of a NanoString BASE47 bladder cancer gene classifier
Jordan Kardos, Tracy L Rose, Ujjawal Manocha, et al.
Journal of the American College of Radiology : JACR
|
November 2, 2024
ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update
, Samantha J Barker, Esra Soylu, et al.
Current Problems in Cancer
|
April 21, 2023
Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot
Asia N Matthew-Onabanjo, Gabrielle Nortey, Richard S Matulewicz, et al.
Page
of 7